S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oncolytics Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Oncolytics Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oncolytics Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oncolytics Biotech | 20-F: Registration statement / Annual report / Transition report
Oncolytics Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Oncolytics Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oncolytics Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Oncolytics Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oncolytics Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oncolytics Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data